Physician profile
Laureen Eick-Benson
NPI 1871776393
$1,580.71
in general payments reported to CMS, 2019-2025
16 companies · $363 in 2025
The $363 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $240 · 2022: $375 · 2023: $353 · 2024: $250 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $966.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $965.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vifor Pharma, INC. | $296.90 | 2021-2023 | Veltassa, Korsuva |
| Astrazeneca Pharmaceuticals Lp | $217.78 | 2022-2024 | Farxiga |
| Fresenius USA Marketing, INC. | $199.60 | 2021-2025 | Velphoro, Velphoro |
| Ardelyx, INC. | $159.95 | 2024-2025 | Xphozah 30 Mg, Ibsrela |
| Mallinckrodt Hospital Products INC. | $122.85 | 2025 | Terlivaz |
| Amgen INC. | $113.84 | 2021-2022 | |
| Akebia Therapeutics INC | $93.94 | 2021-2025 | Vafseo, Auryxia |
| Glaxosmithkline, LLC. | $86.64 | 2023 | Jesduvroq, Benlysta |
| Calliditas Therapeutics US INC. | $71.33 | 2024-2025 | Tarpeyo |
| Otsuka America Pharmaceutical, INC. | $51.76 | 2023-2025 | Jynarque |
| Bayer Healthcare Pharmaceuticals INC. | $50.83 | 2024 | |
| Horizon Therapeutics Plc | $50.83 | 2021-2022 | |
| Astellas Pharma US INC | $21.31 | 2023 | Cresemba |
| Daiichi Sankyo INC. | $18.32 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.67 | 2023 | Jardiance |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daxor Corporation | $10.16 | 2023 | Bva-100 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laureen Eick-Benson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.